Ali Turkyilmaz,Ali Hasan Turp,Mehtap Saydam,Onur Ulgen
申请号：
US15123818
公开号：
US09795592B2
申请日:
2015.03.05
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to a pharmaceutical formulation comprising therapeutically effective amount of vildagliptin or pharmaceutically acceptable salt thereof and a diluent. Particularly, the ratio of vildagliptin to diluent is in the range of 0.04 to 0.24 (w/w).
